SCHEMBL5218794

SCHEMBL5218794

Cc1ccc(-n2cc(-c3nc4ccccc4o3)cn2)c(C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 12/20 0.48
▸ RAB9A P51151 11/20 0.48
▸ KDM4E B2RXH2 10/20 0.48
▸ SMN1; SMN2 Q16637 9/20 0.48
▸ HPGD P15428 9/20 0.48
▸ CASP3 P42574 2/20 0.48
▸ SENP8 Q96LD8 2/20 0.48
▸ SENP7 Q9BQF6 2/20 0.48
▸ SENP6 Q9GZR1 2/20 0.48
▸ POLB P06746 1/20 0.48
▸ ALDH1A1 P00352 10/20 0.44
▸ HSD17B10 Q99714 6/20 0.44
▸ TP53 P04637 3/20 0.44
▸ MAPT P10636 6/20 0.44
▸ HCRTR1 O43613 2/20 0.44
▸ USP2 O75604 2/20 0.44
▸ TSHR P16473 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5215874 0.88 NPC1 (0.46) NPC1RAB9AKDM4ESMN1; SMN2HPGD
SCHEMBL14381085 0.83 NPC1 (0.43) NPC1RAB9AKDM4ESMN1; SMN2HPGD
SCHEMBL5224725 0.81 NPC1 (0.47) NPC1RAB9AKDM4ESMN1; SMN2HPGD
SCHEMBL5216455 0.81 NPC1 (0.42) NPC1RAB9AKDM4ESMN1; SMN2HPGD
SCHEMBL5218678 0.80 PTPN2 (0.46) NPC1RAB9AKDM4ESMN1; SMN2HPGD
SCHEMBL5217836 0.79 ALDH1A1 (0.50) NPC1RAB9AKDM4ESMN1; SMN2HPGD
SCHEMBL5217497 0.79 SMN1; SMN2 (0.48) NPC1RAB9AKDM4ESMN1; SMN2HPGD
SCHEMBL5217080 0.77 NPC1 (0.45) NPC1RAB9AKDM4ESMN1; SMN2HPGD
SCHEMBL5219184 0.77 RAB9A (0.44) NPC1RAB9AKDM4ESMN1; SMN2HPGD
SCHEMBL5217963 0.77 NPC1 (0.46) NPC1RAB9AKDM4ESMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458383-B1 HETEROARYL SUBSTITUTED PYRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO INC (US) 2007-11-21 — — EP claimed
EP-1458383-A4 HETEROARYL SUBSTITUTED PYRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO INC (US) 2005-05-25 — — EP claimed
EP-1458383-A2 HETEROARYL SUBSTITUTED PYRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 Merck & Co., Inc. (US) 2004-09-22 — — EP claimed
WO-2004030637-A2 TREATMENT OF OBESITY AND OTHER DISORDERS ASSOCIATED WITH EXCESSIVE FOOD INTAKE MERCK & CO., INC. (US) 2004-04-15 — — WO claimed
WO-2003051833-A2 HETEROARYL SUBSTITUTED PYRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO., INC. (US) 2003-06-26 — — WO claimed
US-7569592-B2 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 MERCK & CO., INC. (US) 2009-08-04 — — US disclosed
US-7569592-B2 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 MERCK & CO., INC. (US) 2009-08-04 — — US disclosed
Send feedback